In the article by Compagne et al, “Endovascular Treatment: The Role of Dominant Caliber M2 Segment Occlusion in Ischemic Stroke,” which published online ahead of print on January 21, 2019, and appeared in the February 2019 issue of the journal (Stroke. 2019. doi: 10.1161/STROKEAHA.118.023117), a correction is needed.
The affiliations listed on page 419 should appear as:
From the Department of Radiology and Nuclear Medicine (K.C.J.C., P.M.v.d.S., A.v.d.L., A.C.G.M.v.E.), Department of Neurology (K.C.J.C., B.R.,M.J.H.L.M., D.W.J.D.), and Department of Public Health (H.F.L.), Erasmus MC, University Medical Center, Rotterdam, the Netherlands; Department of Neurology (I.R.v.d.W.) and Department of Radiology (G.J.L.à.N.), Haaglanden Medical Center (HMC), The Hague, the Netherlands; Department of Neurology, Leiden University Medical Center, the Netherlands (I.R.v.d.W.); Department of Radiology, Maastricht University Medical Center, the Netherlands (W.H.v.Z.); Cardiovascular Research Institute Maastricht, the Netherlands (W.H.v.Z.); Department of Radiology and Nuclear Medicine, Amsterdam University Medical Center, the Netherlands (B.J.E., C.B.L.M.M.); Division of Neurointervention, Texas Stroke Institute, Dallas-Fort Worth (A.J.Y.).
“University Medical Center Utrecht” was corrected to “University Medical Center” in the Methods section (page 420), in the Appendix (page 426), and in the Sources of Funding section (page 426).
This correction has been made to the current online version of the article, which is available at https://www.ahajournals.org/doi/10.1161/STROKEAHA.118.023117.